The Use of Carnoy’s Solution and Its Modifications for Reducing the Number of Recurrences after Surgical Removal of Keratocystic Odontogenic Tumors and Ameloblastomas: A Systematic Review
- 5 Downloads
The paper is a systematic review of using the pharmaceutical substance, Carnoy’s solution, to reduce the number of recurrences of such tumors as keratocystic odontogenic tumor and ameloblastoma. These are benign yet aggressive jaw tumors with a high percentage of recurrences (up to 60–80%). Surgical treatment of the above-described lesions can be performed using: (1) marsupialization (recurrence rate up to 24.8%); (2) enucleation with or without adjunct therapy; therapy may include cryotherapy with liquid nitrogen (recurrence rate up to 23.1%), peripheral ostectomy (recurrence rate up to 20%), and bone cavity treatment with Carnoy’s solution (recurrence rate up to 6.6%); (3) marginal/segmental resection of the jaw (recurrence rate up to 2.5%). Despite the low percentage of recurrences when using marginal/segmental resection, this method requires a longer and more expensive anesthetic and surgical intervention as well as longer postoperative and rehabilitation periods. With the use of Carnoy’s solution, it became possible to reduce the risks of recurrence of keratocystic odontogenic tumors and ameloblastomas from 60–80 to 6.6‒11.5%. Worldwide today, not only Carnoy’s solution recommended by Cutler and Zollinger in 1933 is applied but also its modifications that are not inferior to the original substance in terms of removal efficiency of the remaining cystic cells. The safety of the use of the solution near the vessels and nerves is confirmed by works of a number of authors. It is concluded that, despite the large number of surgical treatments of both keratocystic odontogenic tumors and ameloblastomas, enucleation with the use of Carnoy’s solution is the optimal method of choice for these diseases.
Keywords:keratocystic odontogenic tumor ameloblastoma Carnoy`s solution recurrence surgical treatment enucleation.
COMPLIANCE WITH ETHICAL STANDARDS
Conflict of interests. The authors declare that they have no conflict of interest.
Statement of compliance with standards of research involving humans as subjects. All scans were performed with consent of the patients and were in accordance with ethical standards of the Ethics Committee of the Central Research Institute of Dental and Maxillofacial Surgery.
- 1.Philipsen, H.P., On keratocysts in the jaws, Tandlaegebladet, 1956, vol. 60, pp. 963–980.Google Scholar
- 2.de Molon, R.S., Verzola, M.H., Pires, L.C., Masca-renhas, V.I., da Silva, R.B., Cirelli, J.A., and Roberto, H.B., Five years follow-up of a keratocyst odontogenic tumor treated by marsupialization and enucleation: A case report and literature review, Contemp. Clin. Dent., 2015, vol. 6, suppl. 1, pp. 106–110.CrossRefGoogle Scholar
- 3.Philipsen, H.P., Keratocystic odontogenic tumour, Pathology and Genetics of Head and Neck Tumours. WHO Classification of Tumours, Barnes, L., Eveson, J.W., Reichart, P., and Sidransky, D., Eds., Lyon: IARC, 2005, 3rd ed., vol. 9, pp. 306–307.Google Scholar
- 5.Ljubenović, M., Ljubenović, D., Binić, I., Jovanović, D., and Stanojević, M., Gorlin-Goltz syndrome, Acta Dermatovenerol. Alp. Pannonica Adriat., 2007, vol. 16, no. 4, pp. 166–169.Google Scholar
- 6.Leger, M., Quintana, A., Tzu, J., Yee, H., Kamino, H., and Sanchez, M., Nevoid basal cell carcinoma syndrome, Dermatol. Online J., 2011, vol. 17, no. 10, p. 23.Google Scholar
- 7.Soufir, N., Gerard, B., Portela, M., Brice, A., Liboutet, M., Saiag, P., Descamps, V., Kerob, D., Wolkenstein, P., Gorin, I., Lebbe, C., Dupin, N., Crickx, B., Basset-Seguin, N., and Grandchamp, B., PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: A French study, Br. J. Cancer, 2006, vol. 95, no. 4, pp. 548–553.CrossRefGoogle Scholar
- 9.Pustinskii, I.N., Kropotov, M.A., Tkachev, S.I., Paches, A.I., Alieva, S.B., Yagubov, A.S., Bazhutova, G.A., and Slanina, S.V., Treatment of patients with squamous cell carcinoma of the scalp and neck, Ross. Oncol. Zh., 2013, no. 1, pp. 42–46.Google Scholar
- 10.Berenbeyn, B.A., Lezvinskaya, E.M., Krasnoshchekova, N.Yu., and Ilinskaya, T.B., Gorlin-Golts syndrome, Vestn. Dermatol., 1993, no. 5, pp. 63–67.Google Scholar
- 11.Guimarães, A.C., Santos, M.D.D.C.F., de Carvalho, G.M., Chone, C.T., and Pfeilsticker, L.N., Giant keratocystic odontogenic tumor: Three cases and literature review, Iran. J. Otorhinolaryngol., 2013, vol. 25, no. 73, pp. 245–252.Google Scholar
- 14.Yashoda Devi, B.K., Rakesh, N., Nisha, A., Sagar, P., and Prasad, K., Bilateral keratocystic odontogenic tumor of mandible, Indian J. Multidiscip. Dent., 2010, vol. 1, no. 1, pp. 12–14.Google Scholar
- 16.Jafaripozve, N., Jafaripozve, S., and Khorasgani, M.A., Kerathocyst odontogenic tumor: Importance of selection the best treatment modality and a periodical follow-up to prevent from recurrence: A case report and literature review, Int. J. Prev. Med., 2013, vol. 4, no. 8, pp. 967–970.Google Scholar
- 20.Semkin, V.A., Grigor’yan, A.S., Babichenko, I.I., Usachev, E.S., and Zaretskaya, A.S., Features of surgical tactics in various forms of ameloblastic tumors, Stomatologiya, 2012, vol. 91, no. 4, pp. 25–27.Google Scholar
- 24.Semkin, V.A., Babichenko, I.I., Usachev, E.S., and Zaretskaya, A.S., Clinical and morphological characteristics of ameloblastomas, Stomatologiya, 2013, vol. 92, no. 4, pp. 40–43.Google Scholar
- 25.Gardner, D.G., Heikinheimo, K., Shear, M., Philipsen, H.P., and Coleman, H., Ameloblastomas, in Pathology and Genetics of Head and Neck Tumours. WHO Classification of Tumours, Barnes, L., Eveson, J.W., Reichart, P., and Sidransky, D., Eds., Lyon: IARC, 2005, 3rd ed., vol. 9, pp.298–302.Google Scholar
- 31.Kirichenko, E.N., The use of stereolithographic modeling in patients with mandibular ameloblastoma, Al’m. Sovrem. Nauki Obraz., 2014, vols. 5–6, no. 84, pp. 78–82.Google Scholar
- 34.Al-Moraissi, E.A., Dahan, A.A., Alwadeai, M.S., Oginni, F.O., Al-Jamali, J.M., Alkhutari, A.S., Al-Tairi, N.H., Almaweri, A.A., and Al-Sanabani, J.S., What surgical treatment has the lowest recurrence rate following the management of keratocystic odontogenic tumor?: A large systematic review and meta-analysis, J. Cranio Maxillofac. Surg., 2017, vol. 45, no. 1, pp. 131–144.CrossRefGoogle Scholar
- 38.Madhulaxmi, M. and Abdul Wahab, P.U., Carnoy’s solution as a surgical medicament in the treatment of KCOT, Int. J. Pharma Bio Sci., 2014, vol. 5, no. 1, pp. 492–495.Google Scholar
- 44.Nakamura, N., Mitsuyasu, T., Mitsuyasu, Y., Taketomi, T., Higuchi, Y., and Ohishi, M., Marsupialization for odontogenic keratocysts: Long-term follow-up analysis of the effects and changes in growth characteristics, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2002, vol. 94, no. 5, pp. 543–553.CrossRefGoogle Scholar
- 45.Afanas'ev, V.V., Khirurgicheskaya stomatologiya (Surgical Dentistry), Moscow: GEOTAR-Media, 2011.Google Scholar
- 49.Tolstunov, L. and Treasure, T., Surgical treatment algorithm for odontogenic keratocyst: combined treatment of odontogenic keratocyst and mandibular defect with marsupialization, enucleation, iliac crest bone graft, and dental implants, J. Oral Maxillofac. Surg., 2008, vol. 66, no. 5, pp. 1025–1036.CrossRefGoogle Scholar